31 Russell-Jones D, Vaag A, Schmitz O, et al. Liraglutide vs insulin  glargine and placebo in combination with metformin and sulfonylurea therapy in type 2 diabetes mellitus (LEAD-5 met+SU): a randomised controlled trial. Diabetologia 2009;  52: 2046–55.  32  Grimm M, Li Y , Brunell SC, Blase E. Exenatide once weekly  versus daily basal insulin as add-on treatment to metformin with or without a sulfonylurea: a retrospective pooled analysis in patients with poor glycemic control. Postgrad Med 2013; 125: 101–08.  33 Diamant M, Peters A, Russell-Jones D, et al. Is insulin the most  eﬀ  ective injectable HbA 1c-lowering therapy? Diabetologia 2012;  55: S329–30.